A clinical questing examination to verify vasculo-protective effect of azilsartan treatment in the uncontrolled hypertensive patients with diabetes mellitus.

Not Applicable

• Conditions: Japanese hypertensive patients with diabetes mellitus.

• Registration Number: JPRN-UMIN000011892
• Lead Sponsor: Tohoku University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) Corresponding to the GFR < 30 ml/min/1.73m2, or receiving continuous dialysis. 2) Woman who has pregnancy or possibility of pregnancy and suckling. 3) To have other serious and active diseases such as severe hyperglycemia (HbA1c > 10%), liver dysfunction, cardiovascular disease, malignancies and so on). 4) Severe hypertensive subjects (> 180 / 110 mmHg). 5) The patient that corresponds to taking of Aliskiren treatment. 6) The patient with renal artery stenosis, 7) The patient whose serum potassium level is more than 5.5, 8) Patient from whom physician in charge of treatment judged this study participation to be improper.

Study & Design

• Study Type: Interventional
• Study Design: Not specified